2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation
Clinical trial NCT04433091 · COMPLETED
Trial details
- NCT number
- NCT04433091
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2022-01-30
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.